The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global HPV Testing Market Research Report 2024
Synopsis
The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing, co-testing, HPV primary testing.
The global HPV Testing market was valued at US$ 802 million in 2023 and is anticipated to reach US$ 1410.6 million by 2030, witnessing a CAGR of 8.3% during the forecast period 2024-2030.
Global HPV Testing key players include Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD, etc. Global top five players hold a share about 80%.
North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent.
In terms of product, Co-testing is the largest segment, with a share about 55%. And in terms of application, the largest application is Cervical Cancer Screening, followed by Vaginal Cancer Screening, etc.
This report aims to provide a comprehensive presentation of the global market for HPV Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HPV Testing.
Report Scope
The HPV Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global HPV Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HPV Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Qiagen
Roche Diagnostics
Hologic
Abbott Laboratories
BD
Seegene, Inc.
Segment by Type
HPV Testing
Follow-up HPV Testing
Co-testing
Segment by Application
Cervical Cancer Screening
Vaginal Cancer Screening
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HPV Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing, co-testing, HPV primary testing.
The global HPV Testing market was valued at US$ 802 million in 2023 and is anticipated to reach US$ 1410.6 million by 2030, witnessing a CAGR of 8.3% during the forecast period 2024-2030.
Global HPV Testing key players include Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD, etc. Global top five players hold a share about 80%.
North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent.
In terms of product, Co-testing is the largest segment, with a share about 55%. And in terms of application, the largest application is Cervical Cancer Screening, followed by Vaginal Cancer Screening, etc.
This report aims to provide a comprehensive presentation of the global market for HPV Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HPV Testing.
Report Scope
The HPV Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global HPV Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HPV Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Qiagen
Roche Diagnostics
Hologic
Abbott Laboratories
BD
Seegene, Inc.
Segment by Type
HPV Testing
Follow-up HPV Testing
Co-testing
Segment by Application
Cervical Cancer Screening
Vaginal Cancer Screening
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HPV Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HPV Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 HPV Testing
1.2.3 Follow-up HPV Testing
1.2.4 Co-testing
1.3 Market by Application
1.3.1 Global HPV Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cervical Cancer Screening
1.3.3 Vaginal Cancer Screening
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global HPV Testing Market Perspective (2019-2030)
2.2 HPV Testing Growth Trends by Region
2.2.1 Global HPV Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 HPV Testing Historic Market Size by Region (2019-2024)
2.2.3 HPV Testing Forecasted Market Size by Region (2025-2030)
2.3 HPV Testing Market Dynamics
2.3.1 HPV Testing Industry Trends
2.3.2 HPV Testing Market Drivers
2.3.3 HPV Testing Market Challenges
2.3.4 HPV Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HPV Testing Players by Revenue
3.1.1 Global Top HPV Testing Players by Revenue (2019-2024)
3.1.2 Global HPV Testing Revenue Market Share by Players (2019-2024)
3.2 Global HPV Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by HPV Testing Revenue
3.4 Global HPV Testing Market Concentration Ratio
3.4.1 Global HPV Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HPV Testing Revenue in 2023
3.5 HPV Testing Key Players Head office and Area Served
3.6 Key Players HPV Testing Product Solution and Service
3.7 Date of Enter into HPV Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HPV Testing Breakdown Data by Type
4.1 Global HPV Testing Historic Market Size by Type (2019-2024)
4.2 Global HPV Testing Forecasted Market Size by Type (2025-2030)
5 HPV Testing Breakdown Data by Application
5.1 Global HPV Testing Historic Market Size by Application (2019-2024)
5.2 Global HPV Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America HPV Testing Market Size (2019-2030)
6.2 North America HPV Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America HPV Testing Market Size by Country (2019-2024)
6.4 North America HPV Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HPV Testing Market Size (2019-2030)
7.2 Europe HPV Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe HPV Testing Market Size by Country (2019-2024)
7.4 Europe HPV Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HPV Testing Market Size (2019-2030)
8.2 Asia-Pacific HPV Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific HPV Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific HPV Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HPV Testing Market Size (2019-2030)
9.2 Latin America HPV Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America HPV Testing Market Size by Country (2019-2024)
9.4 Latin America HPV Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HPV Testing Market Size (2019-2030)
10.2 Middle East & Africa HPV Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa HPV Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa HPV Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Qiagen
11.1.1 Qiagen Company Detail
11.1.2 Qiagen Business Overview
11.1.3 Qiagen HPV Testing Introduction
11.1.4 Qiagen Revenue in HPV Testing Business (2019-2024)
11.1.5 Qiagen Recent Development
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Detail
11.2.2 Roche Diagnostics Business Overview
11.2.3 Roche Diagnostics HPV Testing Introduction
11.2.4 Roche Diagnostics Revenue in HPV Testing Business (2019-2024)
11.2.5 Roche Diagnostics Recent Development
11.3 Hologic
11.3.1 Hologic Company Detail
11.3.2 Hologic Business Overview
11.3.3 Hologic HPV Testing Introduction
11.3.4 Hologic Revenue in HPV Testing Business (2019-2024)
11.3.5 Hologic Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Detail
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories HPV Testing Introduction
11.4.4 Abbott Laboratories Revenue in HPV Testing Business (2019-2024)
11.4.5 Abbott Laboratories Recent Development
11.5 BD
11.5.1 BD Company Detail
11.5.2 BD Business Overview
11.5.3 BD HPV Testing Introduction
11.5.4 BD Revenue in HPV Testing Business (2019-2024)
11.5.5 BD Recent Development
11.6 Seegene, Inc.
11.6.1 Seegene, Inc. Company Detail
11.6.2 Seegene, Inc. Business Overview
11.6.3 Seegene, Inc. HPV Testing Introduction
11.6.4 Seegene, Inc. Revenue in HPV Testing Business (2019-2024)
11.6.5 Seegene, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
